ABCG2 and lung cancer: As brain metastases can occur in different tumor types, especially lung cancer, the potential interaction between selpercatinib and ABCB1/ABCG2 in vivo may not only limit selpercatinib oral exposure but also its brain accumulation, and thus affect therapeutic efficacy for brain metastases in lung cancer patients.